Biomarkers of lung cancer based on the expression of genes, transposons and repetitive elements

M. Arroyo Varela (Malaga, Spain), E. Salcedo Lobera (Malaga, Spain), R. Larrosa Jiménez (Malaga, Spain), M. Claros Díaz (Malaga, Spain), R. Bautista Moreno (Malaga, Spain)

Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Session: Molecular alterations and immunology in lung cancer
Session type: E-poster session
Number: 1652
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Arroyo Varela (Malaga, Spain), E. Salcedo Lobera (Malaga, Spain), R. Larrosa Jiménez (Malaga, Spain), M. Claros Díaz (Malaga, Spain), R. Bautista Moreno (Malaga, Spain). Biomarkers of lung cancer based on the expression of genes, transposons and repetitive elements. 1652

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Correlation in expression change between transposons and adjacent genes reveal importance of genomic location in lung cancer.
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019


Identification of the mobile elements differentially expressed in lung cancer
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017


Polymorphisms in telomere maintenance genes and risk of lung cancer
Source: Annual Congress 2009 - Pathogenesis of lung cancer
Year: 2009



Metal elements as early biomarkers of lung cancer
Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Year: 2019


Identification of reference genes in lung cancer from RNA-seq data
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017


Differential expression analysis of lncRNA in different types of lung cancer
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021


Polymorphisms in cancer-related pathway genes and lung cancer
Source: Eur Respir J 2016; 48: 1184-1191
Year: 2016



LSC - 2017 - Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017

DNA methylation markers of surfactant proteins in lung cancer
Source: Annual Congress 2007 - Novel mediators of cellular pathology
Year: 2007


LSC - 2020 - Transcriptome signatures of tobacco carcinogens hint the alteration of TAF6 as a specific feature in smokers lung cancer
Source: Virtual Congress 2020 – Novel methods, diagnostics and biomarkers of chronic lung diseases
Year: 2020

Where next for lung cancer gene expression profiling?
Source: Eur Respir J 2007; 30: 5-6
Year: 2007


Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes
Source: ERS Lung Science Conference 2017
Year: 2017

Alteration patterns of tobacco carcinogens in lung adenocarcinoma reveal novel KRAS-addicted candidate oncogenes
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018


Lung cancer biomarkers based on miRNA
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021


Comparative gene expression analysis in lung cancer
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018


Identifying a tissue specific microRNA molecular signature in lung cancer
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021


Defining lineage relationships of multiple lung tumors through shared large genomic rearrangements
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013

Which gene expression signatures in pharmacogenomic strategies for lung cancer?
Source: Annual Congress 2010 - Customised chemotherapy for lung cancer
Year: 2010


Recognition of aberrant promoter methylation for early diagnosis of lung cancer patients
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020